MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Prim-O-glucosylcimifugin

CAS No. : 80681-45-4

MCE 站：Prim-O-glucosylcimifugin

产品活性：Prim-O-glucosylcimifugin 具有强效的抗炎作用。通过调节 JAK2/STAT3 信号传导可抑制 iNOS 和 COX-2 表达。

研究领域：Immunology/Inflammation

作用靶点：NO Synthase  |  COX

In Vitro: Prim-O-glucosylcimifugin (POG) is the highest content chromone and one of the major active constituents in Radix Saposhnikoviae (RS). Prim-O-glucosylcimifugin exerts anti-inflammatory effects in RAW 264.7 macrophages through the inhibition of iNOS and COX-2 expression by inhibiting JAK2/STAT3 signaling. The cytotoxicity of Prim-O-glucosylcimifugin is measured to LPS-activated Raw 264.7 macrophages. Raw 264.7 macrophages are treated with LPS (1 μg/mL) and increasing concentrations of Prim-O-glucosylcimifugin (15, 50, and 100 μg/mL) for 24 h and cell viability is evaluated by CCK-8 assay. Cell viability is not significantly affected after 24 h and exposure to 15-100 μg/mL Prim-O-glucosylcimifugin as compared with DMSO-treated cells (control). To investigate the anti-inflammatory effect of Prim-O-glucosylcimifugin, whether Prim-O-glucosylcimifugin can affect NO synthesis is examined in LPS-activated RAW 264.7 cells. Macrophages are treated with LPS (1 μg/mL) and various concentrations of Prim-O-glucosylcimifugin (15, 50, and 100 μg/mL) for 24 h. No concentrations are measured in the culture supernatants by Griess reaction. The concentrations of NO in the culture supernatants are markedly increased in response to LPS exposure, and Prim-O-glucosylcimifugin significantly inhibits LPS-induced NO production in a concentration-dependent manner.

In Vivo: Bronchoalveolar lavage fluid (BALF) is collected at 7 h after lipopolysaccharide (LPS) administration and thecytokine levels in BALF are measured by ELISA. The levels of TNF-α, IL-1β and IL-6 in BALF are increased dramatically compared with control group. However, pretreatment with Prime-O-glucosylcimifugin (2.5, 5 or 10 mg/kg) significantly down-regulates the levels of TNF-α, IL-1β and IL-6 in a dose-dependent manner (P<0.05, P<0.01).

相关产品：Natural Product Library Plus  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Natural Product Library  |  Anti-Aging Compound Library  |  Pyroptosis Compound Library  |  Traditional Chinese Medicine Monomer Library  |  Neuroprotective Compound Library  |  Anti-Pancreatic Cancer Compound Library  |  Acetaminophen  |  Mifepristone  |  Indomethacin  |  L-NAME hydrochloride  |  Celecoxib  |  Aspirin  |  Ibuprofen  |  L-NMMA acetate  |  1400W Dihydrochloride  |  Catechin  |  L-Arginine  |  NS-398  |  S-Nitroso-N-acetyl-DL-penicillamine  |  Diclofenac  |  20(S)-Ginsenoside Rg3  |  Methylene Blue  |  Naproxen  |  (-)-Epicatechin  |  Gallic acid  |  Xanthohumol  |  Sulindac  |  Asymmetric dimethylarginine  |  SC-560  |  Carprofen  |  Isoquercetin  |  Salicylic acid  |  Meloxicam  |  Rutaecarpine  |  Rebamipide

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。